HCA Healthcare Inc. ($HCA) Stock Forecast: Down 0.7% Today

What is HCA Healthcare Inc.?

A major healthcare services provider, HCA Healthcare (HCA), has a market capitalization of $102.46 billion and a strong historical performance, averaging an annual return of 18.29%.

Why is HCA Healthcare Inc. going down?

HCA stock is down 0.7% on Sep 11, 2024 14:36

• Despite its strong historical performance, HCA Healthcare (HCA) faced a bearish market movement today.
• Investor focus may have shifted towards the bullish movement in Cigna Group (CI) stock, which has benefited from improved premiums and buyouts.
• The recent acquisition news of Valir Rehabilitation Hospital by Select Medical (SEM) within the healthcare sector may have influenced investor attention, impacting HCA Healthcare's stock negatively.
• Comparisons of HCA Healthcare's performance with other medical stocks like Arbutus Biopharma (ABUS) may have revealed relative underperformance, potentially contributing to today's bearish trend.

HCA Price Chart

HCA News

Cigna Stock Gains 26% in a Year: What Lies Ahead for Investors? - Cigna ( NYSE:CI ) , Ensign Group ( NASDAQ:ENSG )

Shares of The Cigna Group CI have gained 25.6% in the past year compared with the industry's 18.2% growth. The Medical sector and the S&P 500 composite index have rallied 9.3% and 21.2%, respectively, in the same time frame.

https://www.benzinga.com/news/earnings/24/09/40801255/cigna-stock-gains-26-in-a-year-what-lies-ahead-for-investors

Cigna Stock Gains 26% in a Year: What Lies Ahead for Investors?

CI benefits from improved premiums resulting from an extensive customer base. Buyouts and adequate operating cash flows are other tailwinds.

https://www.zacks.com/stock/news/2334211/cigna-stock-gains-26-in-a-year-what-lies-ahead-for-investors

Are Medical Stocks Lagging HCA Healthcare ( HCA ) This Year?

Here is how HCA Healthcare (HCA) and Arbutus Biopharma (ABUS) have performed compared to their sector so far this year.

https://www.zacks.com/stock/news/2333384/are-medical-stocks-lagging-hca-healthcare-hca-this-year

Here's How Much $100 Invested In HCA Healthcare 10 Years Ago Would Be Worth Today - HCA Healthcare ( NYSE:HCA )

HCA Healthcare HCA has outperformed the market over the past 10 years by 7.84% on an annualized basis producing an average annual return of 18.29%. Currently, HCA Healthcare has a market capitalization of $102.46 billion.

https://www.benzinga.com/insights/news/24/09/40752516/heres-how-much-100-invested-in-hca-healthcare-10-years-ago-would-be-worth-today

Select Medical Agrees to Acquire Valir Rehabilitation Hospital

SEM enters a definitive agreement to acquire Valir Rehabilitation Hospital and expand its inpatient rehabilitation footprint in Oklahoma City.

https://www.zacks.com/stock/news/2332374/select-medical-agrees-to-acquire-valir-rehabilitation-hospital

Trending Today

Sei ($SEI) Crypto Forecast: Up 5.5% Today

Solana ($SOL) Crypto Forecast: Up 8.8% Today

Sui ($SUI) Crypto Forecast: Up 8.5% Today

Ethereum ($ETH) Crypto Forecast: Up 5.4% Today

dogwifhat ($WIF) Crypto Forecast: Up 8.6% Today

Bonk ($BONK) Crypto Forecast: Up 6.1% Today

Worldcoin ($WLD) Crypto Forecast: Up 5.2% Today

Avalanche ($AVAX) Crypto Forecast: Up 9.9% Today

Jupiter ($JUP) Crypto Forecast: Up 13.4% Today

Chainlink ($LINK) Crypto Forecast: Up 5.4% Today

HCA Healthcare Inc. Price History

11.08.2024 - HCA Stock was down 0.7%

• Despite its strong historical performance, HCA Healthcare (HCA) faced a bearish market movement today.
• Investor focus may have shifted towards the bullish movement in Cigna Group (CI) stock, which has benefited from improved premiums and buyouts.
• The recent acquisition news of Valir Rehabilitation Hospital by Select Medical (SEM) within the healthcare sector may have influenced investor attention, impacting HCA Healthcare's stock negatively.
• Comparisons of HCA Healthcare's performance with other medical stocks like Arbutus Biopharma (ABUS) may have revealed relative underperformance, potentially contributing to today's bearish trend.

06.08.2024 - HCA Stock was down 0.5%

• HCA stock experienced a bearish movement today, possibly influenced by concerns about governance issues within the organization.
• Despite the long-term potential highlighted regarding the significant returns on investment in HCA Healthcare over the past decade, the current market sentiment might have been impacted by immediate concerns raised by Telangana Cricket Association regarding the HCA's operations.
• The acquisition news from Select Medical expanding its rehabilitation footprint could have also shifted investor focus away from HCA Healthcare, contributing to the bearish movement in HCA stock today.

09.08.2024 - HCA Stock was down 2.1%

• Today's decline in HCA stock could be due to investors taking profits following its sustained outperformance.
• The announcement of Valir Rehabilitation Hospital's acquisition by Select Medical (SEM) may have prompted investors to focus on SEM, leading to a temporary sell-off in HCA shares.
• Despite Centene's (CNC) positive performance and stock growth, some investors may be shifting away from HCA towards other healthcare companies, leading to a negative impact on HCA's stock price.
• The bearish trend in HCA today appears to be a brief market adjustment influenced by broader industry trends and specific corporate updates.

31.00.2024 - HCA Stock was up 5.2%

• HCA reported strong fourth-quarter revenue, exceeding expectations.
• Admissions and equivalent admissions also showed positive growth.
• The company expects higher earnings per share for the next year.
• HCA also announced a dividend increase.
• These positive financial results and expectations, along with the dividend increase, likely contributed to the bullish movement in HCA's stock. The market responded positively to the company's strong performance and outlook for the future.

26.03.2024 - HCA Stock was down 5.1%

• Despite surpassing profit projections and delivering a strong performance in the initial quarter, HCA Healthcare observed a decline in the market.
• The declaration of a shareholder dividend along with Augmedix's introduction of a new product designed for emergency departments may have provided an initial boost to investor confidence.
• Nonetheless, external factors or market sentiment might have contributed to the downturn in HCA stock, despite its favorable financial outcomes.
• Investors could be responding to general market trends or specific industry-related developments, influencing the downward trend in HCA's stock value.

18.03.2024 - HCA Stock was down 5.1%

• The bearish movement in HCA Healthcare's stock price today can be attributed to several factors:
• The decrease in short interest indicates a lack of confidence or potential selling pressure on the stock, which could have contributed to the downward pressure on the price.
• Despite a positive outlook from Deutsche Bank, the overall performance of medical stocks, including HCA Healthcare, might have lagged behind other sectors, leading to investor concerns.
• The stock declining while the broader market improved suggests that specific company-related factors or industry dynamics could be influencing investor sentiment and driving the negative price movement.

18.03.2024 - HCA Stock was down 5.1%

• Smart money investors have taken a bearish stance on HCA Healthcare, with a split sentiment of 33% bullish and 66% bearish, as indicated by unusual options trades.
• The stock fell more than the broader market, closing at $311.03, marking a -0.91% move from the previous day, possibly reflecting the impact of the bearish sentiment.
• HCA Healthcare's short interest has decreased by 12.99%, indicating a potential shift in market sentiment towards the stock.
• Deutsche Bank raised HCA Holdings' stock target on a strong outlook, which might suggest a positive long-term view despite the current bearish movement.

29.04.2024 - HCA Stock was up 3.9%

• The bullish movement in HCA's stock price can be attributed to the overall positive outlook for healthcare stocks in the market, driven by factors such as projected growth in healthcare spending and increasing demand for medical services.
• The decrease in short interest for HCA indicates growing confidence in the company's performance and potential for long-term growth, leading to increased buying pressure on the stock.
• As investors seek stability and upside potential in uncertain economic times, healthcare stocks like HCA present themselves as attractive investment opportunities, supported by strong secular growth drivers and favorable valuations.
• With demographic trends and coverage expansions driving demand for healthcare services, HCA is well positioned to benefit from these tailwinds, making it a compelling choice for investors looking for exposure to the resilient healthcare sector.

28.05.2024 - HCA Stock was down 5.8%

• There is a notable interest from investors in HCA options, with a majority displaying optimistic sentiment. However, despite this, the stock's performance was bearish, suggesting a potential disparity between market sentiment and actual results.
• The focus on Augmedix's AI tool accomplishments and expansion plans might have shifted attention away from HCA Healthcare, impacting its stock negatively.
• Uncertainty surrounding the upcoming 2nd Quarter earnings release call for HCA Healthcare could be prompting some investors to sell off the stock.
• While the healthcare sector as a whole shows a positive outlook, as evidenced by gains in the Health Care Select Sector SPDR Fund, individual company performance like HCA Healthcare can still be influenced by specific factors, contributing to today's downward movement.

28.05.2024 - HCA Stock was down 3.3%

• Today's bearish movement in HCA's stock price could be attributed to several factors:
• Mention of Augmedix's AI tool success and expansion plans could have raised concerns among investors about potential competition in the healthcare technology space, leading to a sell-off of HCA shares.
• The upcoming earnings release call for HCA Healthcare's 2nd Quarter 2024 might have created uncertainty in the market, causing some investors to take a cautious approach and sell off their positions.
• Despite HCA Healthcare's strong historical performance, with a market capitalization of $88.77 billion and consistent annualized returns, recent gains in the broader healthcare sector may have prompted profit-taking by investors looking to capitalize on other opportunities within the industry.
• The positive outlook for healthcare stocks, as reflected in the Health Care Select Sector SPDR Fund's year-to-date gains and the potential for sustained growth in the sector, could have led some investors to reallocate their investments from HCA Healthcare to other healthcare stocks with perceived stronger growth prospects.

23.06.2024 - HCA Stock was up 5.2%

• HCA Healthcare reported strong Q2 earnings, surpassing market expectations and increasing its FY24 outlook, resulting in a bullish movement in the stock.
• The company's decision to elevate its yearly profit forecast demonstrates confidence in healthcare demand, likely boosting investor confidence.
• Revenues rose by 10.3%, and net income increased by 22.5% in Q2 2024, showcasing HCA Healthcare's robust performance and significant growth in admissions and ER visits, contributing to the positive market sentiment.
• Overall, HCA Healthcare's impressive financial and operational results, combined with optimistic guidance, drove the stock upwards as investors positively responded to the company's performance.

23.06.2024 - HCA Stock was up 6.0%

• HCA Healthcare is a for-profit operator of healthcare facilities, including hospitals and clinics. The company provides a wide range of medical services to patients.
• Assessment
• HCA stock experienced a strong bullish movement.
• The company reported impressive Q2 2024 earnings, beating both EPS and revenue estimates.
• HCA Healthcare's raised annual profit forecast indicates confidence in continued strong demand for medical care.
• The positive earnings report and increased profit outlook likely contributed to the bullish market movement of HCA stock.